Literature DB >> 29273303

The impact of two triggered palliative care consultation approaches on consult implementation in oncology.

Lisa D DiMartino1, Bryan J Weiner2, Laura C Hanson3, Morris Weinberger4, Sarah A Birken5, Katherine Reeder-Hayes6, Justin G Trogdon7.   

Abstract

INTRODUCTION: Studies show palliative care delivered concurrently with cancer treatment improves outcomes, yet palliative care integration with inpatient oncology is underused. A promising approach to improve integration is a triggered palliative care consultation (TPCC). This study evaluated the impact of two TPCC approaches on consistency and quality of consult implementation, operationalized as uptake and timeliness, on solid tumor medical and gynecologic oncology services at an academic hospital.
METHODS: The study timeframe was 2010-2016. TPCC in gynecologic oncology began in 2014 and was supported by a single strategy (written guideline); TPCC in medical oncology began in 2015 and was supported by multiple strategies (e.g. training, chart review). Palliative care consult information was chart abstracted and linked to hospital encounter data. We compared the effect of a single strategy vs. usual care, and multiple strategies vs. a single strategy on implementation. Difference-in-differences modified Poisson regression models evaluated whether implementation differed after TPCC; we estimated adjusted relative risk (aRR), controlling for patient demographic and clinical characteristics.
RESULTS: Overall, 8.8% of medical oncology and 11.0% of gynecologic oncology inpatient encounters involved palliative care consultation. In regression analyses, TPCC supported by a single strategy in gynecologic oncology was associated with greater uptake vs. usual care (aRR: 1.45, p < .05), and TPCC supported by multiple strategies in medical oncology was associated with greater uptake vs. a single strategy (aRR: 2.34, p < .001).
CONCLUSION: Across two inpatient oncology services, TPCC supported by multiple strategies had the greatest impact on uptake. How strategies affect sustained use of palliative care consults remains to be investigated.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Implementation effectiveness; Inpatient oncology; Triggered palliative care consultation

Mesh:

Year:  2017        PMID: 29273303      PMCID: PMC6008181          DOI: 10.1016/j.hjdsi.2017.12.001

Source DB:  PubMed          Journal:  Healthc (Amst)        ISSN: 2213-0764


  27 in total

1.  Changing provider behavior: an overview of systematic reviews of interventions.

Authors:  J M Grimshaw; L Shirran; R Thomas; G Mowatt; C Fraser; L Bero; R Grilli; E Harvey; A Oxman; M A O'Brien
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

2.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

3.  End-of-life care for hospitalized patients with lung cancer: utilization of a palliative care service.

Authors:  Barbara Reville; Marshal N Miller; Richard W Toner; JoAnne Reifsnyder
Journal:  J Palliat Med       Date:  2010-10       Impact factor: 2.947

Review 4.  Guiding inpatient quality improvement: a systematic review of Lean and Six Sigma.

Authors:  Justin M Glasgow; Jill R Scott-Caziewell; Peter J Kaboli
Journal:  Jt Comm J Qual Patient Saf       Date:  2010-12

5.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

6.  Palliative care consultation teams cut hospital costs for Medicaid beneficiaries.

Authors:  R Sean Morrison; Jessica Dietrich; Susan Ladwig; Timothy Quill; Joseph Sacco; John Tangeman; Diane E Meier
Journal:  Health Aff (Millwood)       Date:  2011-03       Impact factor: 6.301

7.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

8.  Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center.

Authors:  Nada Fadul; Ahmed Elsayem; J Lynn Palmer; Tao Zhang; Fadi Braiteh; Eduardo Bruera
Journal:  J Palliat Med       Date:  2007-10       Impact factor: 2.947

9.  Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial.

Authors:  Marie Bakitas; Kathleen Doyle Lyons; Mark T Hegel; Stefan Balan; Frances C Brokaw; Janette Seville; Jay G Hull; Zhongze Li; Tor D Tosteson; Ira R Byock; Tim A Ahles
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272

10.  Clinical findings of a palliative care consultation team at a comprehensive cancer center.

Authors:  Navneet Dhillon; Scott Kopetz; Be Lian Pei; Egidio Del Fabbro; Tao Zhang; Eduardo Bruera
Journal:  J Palliat Med       Date:  2008-03       Impact factor: 2.947

View more
  3 in total

1.  The influence of formal and informal policies and practices on health care innovation implementation: A mixed-methods analysis.

Authors:  Lisa D DiMartino; Sarah A Birken; Laura C Hanson; Justin G Trogdon; Alecia S Clary; Morris Weinberger; Katherine Reeder-Hayes; Bryan J Weiner
Journal:  Health Care Manage Rev       Date:  2018 Jul/Sep

2.  Identification of Uncontrolled Symptoms in Cancer Patients Using Natural Language Processing.

Authors:  Lisa DiMartino; Thomas Miano; Kathryn Wessell; Buck Bohac; Laura C Hanson
Journal:  J Pain Symptom Manage       Date:  2021-11-04       Impact factor: 3.612

3.  The feasibility of triggers for the integration of Standardised, Early Palliative (STEP) Care in advanced cancer: A phase II trial.

Authors:  Anna Collins; Vijaya Sundararajan; Brian Le; Linda Mileshkin; Susan Hanson; Jon Emery; Jennifer Philip
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.